{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:49:15Z","timestamp":1782953355817,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200563"],"award-info":[{"award-number":["82200563"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470537"],"award-info":[{"award-number":["82470537"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shaanxi Provincial Science and Technology Program","award":["2025SF-YBXM-037"],"award-info":[{"award-number":["2025SF-YBXM-037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-50112-1","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T06:47:45Z","timestamp":1777704465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fatty acid \u03b2-oxidation-associated prognostic model in gastric cancer and functional validation of IL-6 as a potential therapeutic target"],"prefix":"10.1038","volume":"16","author":[{"given":"Chao","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuetao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjianzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengke","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"issue":"5","key":"50112_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","volume":"20","author":"AP Thrift","year":"2023","unstructured":"Thrift, A. P., Wenker, T. N. & El-Serag, H. B. Global burden of gastric cancer: Epidemiological trends, risk factors, screening and prevention. Nat. Rev. Clin. Oncol. 20(5), 338\u2013349 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"50112_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101404","author":"E Morgan","year":"2022","unstructured":"Morgan, E. et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020\u201340: A population-based modelling study. EClinicalMedicine https:\/\/doi.org\/10.1016\/j.eclinm.2022.101404 (2022).","journal-title":"EClinicalMedicine"},{"key":"50112_CR3","doi-asserted-by":"crossref","unstructured":"Zeng, Y., Jin, R.U., editors. Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer. Seminars in cancer biology; 2022: Elsevier.","DOI":"10.1016\/j.semcancer.2021.12.004"},{"issue":"3","key":"50112_CR4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2174\/0109298665350654250111144722","volume":"32","author":"Q Suyila","year":"2025","unstructured":"Suyila, Q., Li, X. & Su, X. Anti-cancer bioactive peptide induces apoptosis in gastric cancer cells through TP53 signaling cascade. Protein. Pept. Lett. 32(3), 194\u2013205 (2025).","journal-title":"Protein. Pept. Lett."},{"issue":"5","key":"50112_CR5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.2174\/0113892029300694240612081006","volume":"25","author":"Q Li","year":"2024","unstructured":"Li, Q., Chu, Y., Yao, Y. & Song, Q. FAT4 mutation is related to tumor mutation burden and favorable prognosis in gastric cancer. Curr. Genomics. 25(5), 380\u2013389 (2024).","journal-title":"Curr. Genomics."},{"key":"50112_CR6","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429322420241112051105","volume":"17","author":"S Fatima","year":"2024","unstructured":"Fatima, S. et al. Exploring the pharmacological mechanisms of P-hydroxylcinnamaldehyde for treating gastric cancer: A pharmacological perspective with experimental confirmation. Curr. Mol. Pharmacol. 17, e18761429322420 (2024).","journal-title":"Curr. Mol. Pharmacol."},{"issue":"5","key":"50112_CR7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2174\/0113892029300608240531111743","volume":"25","author":"Z Peng","year":"2024","unstructured":"Peng, Z. et al. Crosstalk between cancer-associated fibroblasts and myeloid cells shapes the heterogeneous microenvironment of gastric cancer. Curr. Genomics. 25(5), 390\u2013411 (2024).","journal-title":"Curr. Genomics."},{"issue":"1","key":"50112_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","volume":"27","author":"T Wang","year":"2018","unstructured":"Wang, T. et al. JAK\/STAT3-regulated fatty acid \u03b2-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance. Cell Metab. 27(1), 136\u201350. e5 (2018).","journal-title":"Cell Metab."},{"key":"50112_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216235","volume":"565","author":"Z Chen","year":"2023","unstructured":"Chen, Z. et al. MSC-NPRA loop drives fatty acid oxidation to promote stemness and chemoresistance of gastric cancer. Cancer Lett. 565, 216235 (2023).","journal-title":"Cancer Lett."},{"issue":"7","key":"50112_CR10","doi-asserted-by":"publisher","first-page":"2202956","DOI":"10.1002\/advs.202202956","volume":"10","author":"J Li","year":"2023","unstructured":"Li, J. et al. Tumor cell-intrinsic CD96 mediates chemoresistance and cancer stemness by regulating mitochondrial fatty acid \u03b2-oxidation. Adv. Sci. 10(7), 2202956 (2023).","journal-title":"Adv. Sci."},{"issue":"1","key":"50112_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02928-2","volume":"42","author":"S Cheng","year":"2023","unstructured":"Cheng, S. et al. RGCC-mediated PLK1 activity drives breast cancer lung metastasis by phosphorylating AMPK\u03b12 to activate oxidative phosphorylation and fatty acid oxidation. J. Exp. Clin. Cancer. Res. 42(1), 342 (2023).","journal-title":"J. Exp. Clin. Cancer. Res."},{"issue":"7","key":"50112_CR12","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.7150\/ijbs.70524","volume":"18","author":"Y Fang","year":"2022","unstructured":"Fang, Y. et al. LAMC1-mediated preadipocytes differentiation promoted peritoneum pre-metastatic niche formation and gastric cancer metastasis. Int. J. Biol. Sci. 18(7), 3082 (2022).","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"50112_CR13","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.tem.2023.08.001","volume":"34","author":"ST Orange","year":"2023","unstructured":"Orange, S. T., Leslie, J., Ross, M., Mann, D. A. & Wackerhage, H. The exercise IL-6 enigma in cancer. Trends. Endocrinol. Metab. 34(11), 749\u2013763. https:\/\/doi.org\/10.1016\/j.tem.2023.08.001 (2023).","journal-title":"Trends. Endocrinol. Metab."},{"issue":"44","key":"50112_CR14","doi-asserted-by":"publisher","first-page":"76116","DOI":"10.18632\/oncotarget.18814","volume":"8","author":"L Wang","year":"2017","unstructured":"Wang, L. et al. Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6\/STAT3 signaling pathway. Oncotarget 8(44), 76116 (2017).","journal-title":"Oncotarget"},{"key":"50112_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100396","author":"B Trinh","year":"2021","unstructured":"Trinh, B. et al. Blocking endogenous IL-6 impairs mobilization of free fatty acids during rest and exercise in lean and obese men. Cell Rep. Med. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100396 (2021).","journal-title":"Cell Rep. Med."},{"issue":"8","key":"50112_CR16","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1139\/apnm-2015-0640","volume":"41","author":"T Cullen","year":"2016","unstructured":"Cullen, T., Thomas, A. W., Webb, R. & Hughes, M. G. Interleukin-6 and associated cytokine responses to an acute bout of high-intensity interval exercise: The effect of exercise intensity and volume. Appl. Physiol. Nutr. Metab. 41(8), 803\u2013808 (2016).","journal-title":"Appl. Physiol. Nutr. Metab."},{"issue":"7","key":"50112_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43(7), e47-e (2015).","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"50112_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L.-G., Han, Y. & He, Q.-Y. clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS 16(5), 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"50112_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2021.100141","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation https:\/\/doi.org\/10.1016\/j.xinn.2021.100141 (2021).","journal-title":"Innovation"},{"issue":"11","key":"50112_CR20","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28(11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"50112_CR21","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53(D1), D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"50112_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"50112_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"issue":"6","key":"50112_CR24","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/hep.1840070628","volume":"7","author":"E Christensen","year":"1987","unstructured":"Christensen, E. Multivariate survival analysis using Cox\u2019s regression model. Hepatology 7(6), 1346\u20131358 (1987).","journal-title":"Hepatology"},{"issue":"5","key":"50112_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12(5), 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"issue":"10","key":"50112_CR26","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24(10), 1550\u20131558 (2018).","journal-title":"Nat. Med."},{"key":"50112_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2014-15-3-r47","volume":"15","author":"P Geeleher","year":"2014","unstructured":"Geeleher, P., Cox, N. J. & Huang, R. S. Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines. Genome Biol. 15, 1\u201312 (2014).","journal-title":"Genome Biol."},{"issue":"4","key":"50112_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.155","volume":"10","author":"Y Yang","year":"2020","unstructured":"Yang, Y. et al. MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan-cancer. Clin. Transl. Med. 10(4), e155 (2020).","journal-title":"Clin. Transl. Med."},{"key":"50112_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.605154","volume":"10","author":"W Wang","year":"2020","unstructured":"Wang, W., Bai, L., Li, W. & Cui, J. The lipid metabolic landscape of cancers and new therapeutic perspectives. Front. Oncol. 10, 605154 (2020).","journal-title":"Front. Oncol."},{"key":"50112_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101529","volume":"63","author":"C Zhang","year":"2022","unstructured":"Zhang, C. et al. New dawn for cancer cell death: emerging role of lipid metabolism. Mol. Metabolism. 63, 101529 (2022).","journal-title":"Mol. Metabolism."},{"issue":"3","key":"50112_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41575-022-00703-w","volume":"20","author":"M Alsina","year":"2023","unstructured":"Alsina, M., Arrazubi, V., Diez, M. & Tabernero, J. Current developments in gastric cancer: from molecular profiling to treatment strategy. Nat. Rev. Gastroenterol. Hepatol. 20(3), 155\u2013170 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"50112_CR32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jare.2024.01.028","volume":"67","author":"Y Chen","year":"2025","unstructured":"Chen, Y. et al. Dehydrocostus lactone suppresses gastric cancer progression by targeting ACLY to inhibit fatty acid synthesis and autophagic flux. J. Adv. Res. 67, 331\u2013348 (2025).","journal-title":"J. Adv. Res."},{"issue":"3","key":"50112_CR33","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clinic. 71(3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clinic."},{"issue":"10","key":"50112_CR34","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41577-023-00856-y","volume":"23","author":"S Rose-John","year":"2023","unstructured":"Rose-John, S., Jenkins, B. J., Garbers, C., Moll, J. M. & Scheller, J. Targeting IL-6 trans-signalling: past, present and future prospects. Nat. Rev. Immunol. 23(10), 666\u2013681 (2023).","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"50112_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","volume":"16","author":"EH Choy","year":"2020","unstructured":"Choy, E. H. et al. Translating IL-6 biology into effective treatments. Nat. Rev. Rheumatol. 16(6), 335\u2013345 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"17","key":"50112_CR36","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1158\/0008-5472.CAN-17-2268","volume":"78","author":"TA Karakasheva","year":"2018","unstructured":"Karakasheva, T. A. et al. IL-6 mediates cross-talk between tumor cells and activated fibroblasts in the tumor microenvironment. Cancer Res. 78(17), 4957\u20134970 (2018).","journal-title":"Cancer Res."},{"key":"50112_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-0972-8","volume":"18","author":"I-H Ham","year":"2019","unstructured":"Ham, I.-H. et al. Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer. Mol. Cancer 18, 1\u201314 (2019).","journal-title":"Mol. Cancer"},{"key":"50112_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-016-0561-z","volume":"15","author":"Y-M Pan","year":"2016","unstructured":"Pan, Y.-M. et al. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer. Mol. Cancer 15, 1\u201314 (2016).","journal-title":"Mol. Cancer"},{"issue":"1","key":"50112_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-17439-x","volume":"12","author":"M G\u00f3recka","year":"2022","unstructured":"G\u00f3recka, M., Krzemi\u0144ski, K., Mikulski, T. & Ziemba, A. W. ANGPTL4, IL-6 and TNF-\u03b1 as regulators of lipid metabolism during a marathon run. Sci. Rep. 12(1), 19940 (2022).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50112-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50112-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50112-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:40:34Z","timestamp":1782952834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50112-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50112"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50112-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Human pathological samples from gastric cancer patients were obtained with the approval of the Ethics Committee of the First Affiliated Hospital of Xi\u2019an Jiaotong University. Written informed consent was obtained from all participants prior to their inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"20304"}}